PEGylation of cyanovirin–N, an entry inhibitor of HIV
- 16 August 2007
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 60 (1) , 79-87
- https://doi.org/10.1016/j.addr.2007.05.016
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Engineered VaginalLactobacillusStrain for Mucosal Delivery of the Human Immunodeficiency Virus Inhibitor Cyanovirin-NAntimicrobial Agents and Chemotherapy, 2006
- Emerging Drug Targets for Antiretroviral TherapyDrugs, 2005
- Profile of Resistance of Human Immunodeficiency Virus to Mannose-Specific Plant LectinsJournal of Virology, 2004
- Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophagesEuropean Journal of Immunology, 2003
- The Domain-Swapped Dimer of Cyanovirin-N Is in a Metastable Folded StateStructure, 2002
- Peptide and protein PEGylation: a review of problems and solutionsPublished by Elsevier ,2001
- Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swappingJournal of Molecular Biology, 1999
- Repertoire of Chemokine Receptor Expression in the Female Genital Tract: Implications for Human Immunodeficiency Virus TransmissionThe American Journal of Pathology, 1998
- Solution structure of cyanovirin-N, a potent HIV-inactivating proteinNature Structural & Molecular Biology, 1998
- Construction and Enhanced Cytotoxicity of a [Cyanovirin-N]-[PseudomonasExotoxin] Conjugate against Human Immunodeficiency Virus-Infected CellsBiochemical and Biophysical Research Communications, 1997